Bartter's and Gitelman's syndromes: from gene to clinic

Nephron Physiol. 2004;96(3):p65-78. doi: 10.1159/000076752.

Abstract

Bartter's and Gitelman's syndromes are characterized by hypokalemia, normal to low blood pressure and hypochloremic metabolic alkalosis. Recently, investigators have been able to demonstrate mutations of six genes encoding several renal tubular transporters and ion channels that can be held responsible for Bartter's and Gitelman's syndromes. Neonatal Bartter's syndrome is caused by mutations of NKCC2 or ROMK, classic Bartter's syndrome by mutations of ClC-Kb, Bartter's syndrome associated with sensorineural deafness is due to mutations of BSND, Gitelman's syndrome to mutations of NCCT and Bartter's syndrome associated with autosomal dominant hypocalcemia is linked to mutations of CASR. We review the pathophysiology of these syndromes in relation to their clinical presentation.

Publication types

  • Review

MeSH terms

  • Adolescent
  • Adult
  • Alkalosis / diagnosis
  • Bartter Syndrome / diagnosis*
  • Bartter Syndrome / etiology
  • Bartter Syndrome / genetics*
  • Child
  • Hearing Loss, Sensorineural / genetics
  • Humans
  • Hypokalemia / diagnosis
  • Infant, Newborn
  • Ion Transport
  • Loop of Henle / metabolism
  • Membrane Transport Proteins / genetics
  • Mutation
  • Syndrome

Substances

  • Membrane Transport Proteins